We are delighted to welcome Dr. Hedia Marrakchi, Research Scientist, CNRS – University of Toulouse (France) as a featured speaker at the 2nd International Virtual Conference on Frontiers in TB & Mycobacteriology.
Dr. Marrakchi is an internationally respected scientist in the field of tuberculosis research, with long-standing expertise in mycobacterial lipid metabolism, enzymology, and anti-TB drug discovery. Her work has significantly advanced our understanding of essential mycobacterial pathways and has contributed to the identification and validation of novel drug targets. She has played an active role in collaborative international efforts aimed at accelerating the development of new therapeutics against Mycobacterium tuberculosis.
In this presentation, Dr. Marrakchi will discuss how revisiting established chemical scaffolds can provide fresh opportunities for TB drug discovery. She will highlight strategies for optimizing legacy compounds through modern medicinal chemistry, improving efficacy and selectivity, and overcoming resistance mechanisms. The talk will also explore how integrating biochemical, structural, and biological insights can transform known scaffolds into promising leads for next-generation antituberculosis therapies.
Join global researchers, clinicians, and innovators as we explore inventive strategies shaping the future of TB drug discovery.
Register now and be part of this important global conversation!
Date: March 2–3, 2026
Time/zone: 8am-3:30pm /eastern time, USA
This conference is organized by Impact Research Communications (IRC)
More info: https://tb.ircconferences.net/ | Frontiers in TB & Mycobacteriology
